The Evolving Role of Surgery in Multidisciplinary Care for Sarcoma Patients
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Bone and Soft Tissue Oncology".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 239
Special Issue Editors
Interests: soft tissue sarcoma; immuno-oncology; skin malignancies; the effect of obesity on treatment response
Interests: soft tissue sarcoma; malignant melanoma; palliative medicine
Special Issue Information
Dear Colleagues,
Sarcomas represent a diverse group of malignancies originating from mesenchymal tissues, posing unique challenges in their management due to their varied histological subtypes and anatomical locations. As the cornerstone of definitive treatment, surgical intervention remains pivotal in achieving local control and potentially curative outcomes. Surgery also has a critical therapeutic role in control and palliation of incurable and advanced diseases. This Special Issue of Current Oncology explores the evolving role of surgery within the multidisciplinary care paradigm for patients with sarcoma. We welcome submissions that encompass advances in surgical techniques, integration with adjunctive therapies, and the critical interplay with medical and radiation oncology in management of patients with soft tissue sarcomas, highlighting the importance of a collaborative approach to optimize patient outcomes. Article types can include case reports, systematic reviews, and original research.
Dr. Russell G. Witt
Dr. Elizabeth Lilley
Dr. Heather Lyu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- soft tissue sarcoma
- sarcoma
- surgery
- multidisciplinary approach
- neoadjuvant therapy
- adjuvant therapy
- limb-sparing
- histologic subtypes
- oncologic outcomes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
